JATT II Acquisition Corp

JATT II Acquisition Corp(JATT)股票分析

$10.340

+0.091 (+0.88%)收盘时

Loading chart…
最高
10.340
开盘
10.275
成交量加权均价
10.32
成交量
658.00
市值
—
最低
10.275
成交额
6.79K
企业价值/息税折旧摊销前利润(TTM)
0.00

JATT II Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. The Company is not engaged in any business operations and has not generated any revenue.

AI 分析 of JATT II Acquisition Corp (JATT)

持有

Currently, Zura Bio Ltd (JATT) is not a strong buy due to its low price performance and negative earnings. The stock is trading at $10.25, which is only 1.9% above its 52-week low of $9.99. Additionally, the RSI is at 35.681, indicating that the stock is approaching oversold territory but is not yet a clear buy signal. The forward P/E ratio is 0, showing no expected earnings growth, which raises concerns about its profitability.

估值指标

JATT II Acquisition Corp(JATT)当前预期市盈率为 0.00,5 年平均预期市盈率为 。

预期市盈率

5 年均值 P/E
当前P/E
0.00

预期 EV/EBITDA

5 年均值 EV/EBITDA
当前EV/EBITDA
0.00

预期市销率

5 年均值 P/S
当前P/S
0.00

持有 JATT 的大户

C

Commodore Capital LP

+ 持有JATT

+40.77%

3个月收益率

事件时间线

2026-08-21 (ET)

10:00:00

Jatt II Acquisition Corp Trading Halted Due to Volatility

2026-06-29 (ET)

10:00:00

JATT II Acquisition Corp Ordinary Shares Trading Halted

07:30:00

Talawar Tx and JATT II to Merge, Expected to Raise $285 Million

2026-04-20 (ET)

11:30:00

AEVEX Opens Above $20 in IPO Debut

资讯

JATT 常见问题 —— 由 Alphio AI 解答

JATT II Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. The Company is not engaged in any business operations and has not generated any revenue. It operates in the Financials sector.

Currently, Zura Bio Ltd (JATT) is not a strong buy due to its low price performance and negative earnings. The stock is trading at $10.25, which is only 1.9% above its 52-week low of $9.99. Additionally, the RSI is at 35.681, indicating that the stock is approaching oversold territory but is not yet a clear buy signal. The forward P/E ratio is 0, showing no expected earnings growth, which raises concerns about its profitability.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易